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Significance statement  
Chronic kidney disease of undetermined cause is the leading cause of death among working-age 
adults in a number of Central American countries. This is the first community-based longitudinal study 
undertaken in the at-risk population. The results demonstrate an unprecedented evolution of disease 
with a substantial proportion of initially apparently healthy men and a small proportion of women 
experiencing rapid loss of kidney function over the 2-year follow-up. Although a number of occupational 
risk-factors were identified, the range of study participants that sustained loss of eGFR suggests that 
other factors also play a role. These findings describe a highly prevalent, uniquely aggressive, kidney 
disease with no clear cause. Gaining insight into the etiology should be a global health research priority.  
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ABSTRACT 
Background: There are epidemic levels of chronic kidney disease (CKD) of undetermined cause 
clustering in agricultural communities in low-and-middle income countries, most prominently in Central 
America. We aimed to investigate the natural history of, and factors associated with, loss of kidney 
function in a high-risk population.  
 
Methods: A 2-year prospective community-based longitudinal study with 6-monthly follow-up was 
conducted in nine rural communities in North-western Nicaragua, including all men (n=263) and a 
random sample of women (n=87), aged 18-30, without self-reported CKD, diabetes or hypertension. 
Growth mixture modelling was used to identify subgroups of estimated glomerular filtration rate (eGFR) 
trajectory and weighted multinomial logistic regression to examine associations with proposed risk 
factors. 
 
Results: Three sub-populations of eGFR trajectory among men were identified: 81% remained stable 
(mean baseline eGFR: 116mL/min/1.73m2; mean change in eGFR over follow-up: -
0.6mL/min/1.73m2/year); 9.5% experienced rapid decline despite normal baseline kidney function 
(112mL/min/1.73m2; -18.2mL/min/1.73m2/year); whilst 9.5% had baseline renal dysfunction 
(58mL/min/1.73m2; -3.8mL/min/1.73m2/year). Two sub-populations were identified in women: 96.6% 
remained stable (121mL/min/1.73m2; -0.6mL/min/1.73m2/year); and 3.4% experienced rapid decline 
(132mL/min/1.73m2; -14.2mL/min/1.73m2/year, n=3 cases). Among men, at baseline, outdoor and 
agricultural work along with lack of available shade during work-breaks were associated with rapid 
decline status. 
 
Conclusion: There is an aggressive kidney disease in Nicaragua that is without clear cause. While 
associated with agricultural work the range of study participants that sustained loss of eGFR suggests 
that other factors also play a role.  
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INTRODUCTION 
Chronic kidney disease of undetermined cause (CKDu), also termed Mesoamerican Nephropathy 
(MeN) in Central America, has led to the death of tens of thousands of young adults in rural Nicaragua 
and El-Salvador.1,2 Cross-sectional studies have demonstrated low (<60mL/min/1.73m2) estimated 
glomerular filtration rates (eGFR) at a prevalence of between 2 and 50% among lowland agricultural 
communities in the region.3-6 Forms of CKDu occur in other tropical climates with reports of high 
prevalence in Sri Lanka7,8 (where similar but not identical histopathological findings have been 
reported9), India10 and Egypt11 although whether this represents the same disease entity remains 
unclear.  
Men from communities affected by MeN predominantly work in agriculture, primarily sugar production 
from cane. Agricultural activity in this industry is concentrated in the dry season, which in Nicaragua 
occurs between November and May. Although a leading hypothesis in Mesoamerica is that the disease 
relates to heat stress, a number of other causes, including agrichemicals, infection and heavy metals, 
have been proposed.1,12-14  
Empirical evidence for causes of CKDu has to date been limited to identification of factors associated 
with either reduced eGFR in cross-sectional studies,3,15,16 or loss of eGFR across the harvest season 
in two workplace-based follow-up studies17,18. Given the potential for reverse causation (i.e. reduced 
eGFR resulting in changes in exposure) and misclassification of exposures and/or outcome in the 
cross-sectional designs, along with the non-generalizability, and substantial loss to follow-up that 
occurred in the longitudinal workplace studies, evidence on risk factors for, and evolution of, CKDu is 
extremely limited.19  
Our aim was to investigate the natural history of disease, specifically early loss of kidney function,  
along with risk factors and urinary markers (albumin: creatinine ratio; ACR, and neutrophil 
gelatinase associated lipocalin; NGAL) associated with decline in  eGFR. Therefore, we conducted a 
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community-based longitudinal study of an initially apparently healthy young rural population in 
Northwest Nicaragua. 
METHODS 
Cohort 
Both local and UK based institutional review boards approved the study and participants provided 
written informed consent. The rationale and description of the study design has been published 
elsewhere.20 Briefly, this was a two-year longitudinal community-based study following 350 participants 
aged 18 to 30 years in Leon and Chinandega regions, Nicaragua (Figure 1). Following engagement 
work we performed a census of all adults aged 18-30 in nine rural communities. As we were specifically 
interested in associations with early kidney injury in MeN all potential participants with a self-reported 
diagnosis of chronic kidney disease (CKD), diabetes, or hypertension were excluded. All remaining 
men (as men have been reported to suffer more CKDu), and women selected at random (in numbers 
leading to a male: female ratio of 3:1) were invited to take part. Participants were predominantly 
recruited in November 2014, with an additional 7% in May 2015 as recruitment targets had not been 
met in November. 
Procedures 
Questionnaire data, clinical measurements and biosamples were collected at baseline and then every 
six months until November 2016. Participants were asked to respond to questions on demography, 
occupational history and current job, lifestyle factors and symptoms. Urinary tract infection (UTI) was 
recorded where participants reported a clinical diagnosis (which is common in this part of Nicaragua) 
typically without urinalysis or microbiological confirmation. Body weight was measured with minimal 
clothes using electronic scales and height using a portable stadiometer (both Seca, Birmingham, UK). 
Blood pressure and heart rate was measured in a sitting position using a calibrated digital 
sphygmomanometer (Omron, Kyoto, Japan) after five minutes of quiet seated rest. A mean of three 
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measurements was recorded. Participants were asked to attend fasted, first thing in the morning (prior 
to work) in an attempt to reduce within- and between person variation in serum creatinine.  
Biochemical methods 
Serum creatinine and cystatin C were both measured in a single batch using quality control  referenced 
to international standards (for creatinine: isotope dilution mass-spectrometry quantified National 
Institute of Standards and Technology Standard Reference Material 967). eGFR was calculated using 
the CKD-EPI formula combining creatinine and cystatin C.21 ACR along with semi-quantitative protein 
and specific gravity by test-stick was performed in baseline urine samples thawed for the first time. In 
addition, 55 samples (thawed for a second time) selected using a nested case-control approach were 
analysed for NGAL.  
Statistical methods 
The collection and categorization of exposure variables is described in the Supplementary Material.  
As eGFR trajectories clustered in discrete subgroups (see Supplementary Figure 1), and differently 
between sexes, we used growth mixture modelling (GMM) separately in men and women to empirically 
derive latent classes of eGFR trajectory.22 The GMM is a longitudinal finite mixture model that allows 
identification of unobserved latent classes of individuals following similar progression of the outcome 
over time without imposing a priori constraints on the levels of eGFR or rates of eGFR change (or the 
proportion of participants experiencing any class of change). Each individual’s probability of belonging 
to a particular latent class is derived entirely from the observed eGFR measurements, with individual 
departures from the mean trajectory within each class represented by random effects. We primarily 
used the Bayesian Information Criterion to determine the optimal number of classes as suggested in 
this setting.23 The GMM was estimated by maximum-likelihood using an expectation maximisation (EM) 
algorithm, with confidence intervals for the mean rate of eGFR decline derived using conventional 
standard errors. 
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Each individual was assigned a probability of each class (eGFR trajectory) and then for the purposes 
of the descriptive figure, tables and urinary findings allocated to the highest probability group.   
To test whether proposed causal exposures (alcohol or NSAID use, occupational factors, heat-stress, 
agrochemical exposure, fever, dysuria, water quantity/quality/source in males only) were associated 
with rapidly declining eGFR trajectory we conducted age and educational-level adjusted analyses using 
probability-weighted logistic regression (with weighting according to the participant’s probability of each 
eGFR trajectory as per the GMM) examining exposures individually using stable with preserved eGFR 
trajectory as a reference. Associations where the 95% confidence intervals (CI) of the odds ratio (OR) 
did not include unity were interpreted as significant. We also performed a sensitivity analysis using 
exposures assessed at Visit 2 (only in those men recruited at Visit1) and rapid decline given the 
seasonal variation in occupational exposures. Those with baseline dysfunction were not the primary 
focus of this study but a further analysis additionally exploring associations between risk factors and 
this eGFR trajectory was also performed using probability-weighted logistic regression (see 
Supplementary Material). 
Differences in urinary markers in each eGFR trajectory group (defined based on highest probability as 
above) were investigated either in the whole population for ACR or using a nested-case control 
approach in the case of NGAL. Differences between groups were explored using analysis of variance 
with Dunnett’s post-hoc test. Positive and negative predictive values were calculated for urinary NGAL 
for the rapid decline versus stable group.  
RESULTS 
Cohort and follow-up 
520 adults aged 18-30 were identified in the study communities. After exclusion of 4% of the potential 
participants because of self-reported CKD, diabetes or hypertension, 350 participants (of the 360 
invited after random selection of eligible women; 97%) were included in the study.20 Overall, 
participants attended a total of 1581 study visits over the two-year follow-up (92% of planned visits). 
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Two participants died from end-stage renal disease during the study period. The cohort is described in 
Figure 1 and Table 1.  
The median eGFR in men was 116.2 mL/min/1.73m2 (interquartile range [IQR], 102.4–124.6) at 
baseline, and 110.4 mL/min/1.73m2 (IQR, 92.5–120.5) at end of follow-up. The corresponding figures 
for women were 122.0 mL/min/1.73m2 (IQR, 116.3-127.2) at baseline, and 120.2 mL/min/1.73m2   
(IQR, 110.6-126.6). The eGFR varied by season (Figure 2) with a median of 116.0 mL/min/1.73m2 
(IQR, 102.7-123.8) at the end of the rainy season (November; i.e. pre-sugarcane harvest, all years 
combined) compared to 113.4 mL/min/1.73m2 (IQR, 100.8-122.4) at the end of the dry season (May; 
i.e. post-sugarcane harvest, all years combined). This effect was greatest in those participants with 
lower eGFRs but was also present in those with stable kidney function (Supplementary Table 2). 
eGFR trajectory groups  
Using GMM we identified three different subgroups in men and two in women based on the model 
intercept (baseline eGFR) and slope (change in eGFR over time). Among men (Figure 3A) the majority 
(81%) of men had preserved and stable eGFR, however 9.5% (n=25) had baseline kidney dysfunction 
(eGFR ~60mL/min at recruitment) and a further 9.5% experienced rapid decline in eGFR (with a mean 
loss of 18mL/min/1.72m2/year) despite preserved eGFR at baseline.  Almost all the women (Figure 3B) 
had preserved and stable eGFR but 3.4% (n=3) also experienced rapid decline (with a mean loss of 
14mL/min/1.72m2/year). No differences were seen between communities in the proportions of 
participants in these subgroups.  
Baseline socio-demographic, occupational history, occupational exposures, lifestyle factors, and 
symptoms stratified by the assigned kidney trajectory groups are presented in Supplementary Tables 
2 and 3. The frequencies of indoor work and availability of shade were both lower in the rapidly 
declining subgroup. Of the three women who fell into the rapid decline group, one had worked in (non-
sugarcane) agriculture and two worked exclusively at home.  
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Adjusted associations with rapid decline trajectory 
Baseline age and educational-level adjusted, probability-weighted associations with the rapid decline 
in eGFR trajectory in men using the preserved and stable trajectory as the reference are presented in 
Table 2. Outdoor work (OR, 10.35, 95% CI, 1.35 to 79.24), (non-sugarcane) agricultural work (OR, 
3.57, 95% CI 1.14 to 11.13) and lack of shade available during work breaks (OR, 3.74, 95% CI, 1.59-
8.76) were associated with this outcome. However, we found no evidence for associations between 
rapid decline and years of work in sugarcane, or agriculture; self-reported physical effort in the last 
week at work or occupational heat exposure; self-reported agrochemical exposure over last six months; 
alcohol consumption, self-reported fluid consumption, water quality or source; heat/dehydration-related 
symptoms; or use of NSAIDs.  
We were concerned that the questionnaire administered at baseline might fail to capture important 
occupational exposures as, for most participants, it was conducted 6-months after the harvest season. 
Therefore, we conducted a sensitivity analysis (men recruited at the November visit only, n=213) 
examining the association with the same rapid decline eGFR trajectory as above, and occupational 
exposures, hydration variables and heat-related symptoms captured at the second study visit (May 
2015, immediately post-harvest; Supplementary Table 4). At this time point, no associations were 
detected between working outdoors or lack of shade and rapid decline in eGFR trajectory (although 
very few participants were not exposed). There was an association between both those working in a 
sugarcane cutting role (OR: 3.84 95% CI, 1.17 to 12.58)  and those reporting fever over the last 6-
months (OR: 5.77, 95% CI, 2.03 to 16.33 ) and rapid decline trajectory  but in line with the baseline 
exposure analysis no associations were observed between self-reported measures of heat exposure, 
combined heat-related symptoms, or fluid intake and outcome (Supplementary Table 5).  
Urinary findings 
No associations were found between dipstick proteinuria, specific gravity or ACR and eGFR trajectory 
subgroups (Tables 3 and 4). Urinary NGAL levels among males differed between the three groups 
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tested (Figure 4). The positive and negative predictive values of NGAL ≥5.5pg/mmol for rapid decline 
were 28.5%, and 62.5% respectively.  
 
DISCUSSION 
This is the first community-based cohort study from an area with high reported prevalence of MeN, and 
the first longitudinal study of at least moderate size with follow-up of more than 6 months in area at 
high-risk of disease. Even after excluding those with self-reported CKD, 9.5% of the apparently healthy 
men, but no women, in the study had evidence of baseline renal dysfunction. Rapid loss of eGFR from 
normal baseline levels was found in a further 9.5% of men and 3.4% of women. Among men, risk 
factors at baseline for rapid decline included working outdoors, agricultural work and lack of shade 
availability but none of the other questionnaire responses aimed at capturing heat stress, time-
accumulated occupation or other proposed causes of MeN were associated with the outcome at 
baseline. Due to small numbers, we were unable to examine associations in women.  
Other important findings from our study include the cyclical annual fluctuation in renal function across 
the entire population with the average eGFR approximately 2.5 mL/min/1.73m2 lower following the dry 
(harvest) season as compared to 6-months earlier. Furthermore, although there were no differences 
in albuminuria between those with different kidney function trajectories, urinary NGAL was substantially 
higher among those with baseline dysfunction, and marginally elevated in the rapid decline group. 
Although CKDu has been anecdotally reported as an aggressive disease1, the rate of loss of kidney 
function in the rapid decline group who make up almost 10% of the unselected young male population 
in our study is to our knowledge without precedent. Even when compared to eGFR decline in other 
forms of CKD seen in clinic populations the observed loss of kidney function is alarming. Although a 
recent biopsy study that enrolled patients with established CKDu reported a rate of decline in eGFR of 
7.0mL/min/1.73m2/year among men with a history of work in the sugarcane24 there have been no 
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longitudinal studies which have examined medium- or long-term (>1-year) changes in kidney function 
in the at-risk population. The rate of eGFR decline has been explored in more detail in other forms of 
CKD, for example, a longitudinal study in fifty-five clinic patients with diabetic nephropathy from 
Belgium reported that approximately 15% of patients suffered severe decline in kidney function 
(defined as eGFR loss >4mL/min/1.73m2year).25  Most recently, Boucquemont et al. examined eGFR 
decline in a CKD patient population in France using a similar latent class-based modelling approach to 
that used in this analysis.26 This study reported severe eGFR decline in only 0.6% of patients 
(~50mL/min/1.73m2 over almost 6 years). Therefore, our study findings underline the unique, and 
severe nature of kidney disease in this region. 
The associations with rapid decline trajectory in men suggests that occupation (outdoor agricultural 
work) is an important risk factor for loss of kidney function and is consistent with previous reports18. 
The temporary nature of work in this population makes distinguishing relationships between specific 
occupations and eGFR loss challenging however it is interesting to note that neither time-accumulated 
sugarcane or agricultural work was associated with outcome. Furthermore, the association between 
lack of available shade at baseline, and rapid decline trajectory, suggests that working environment 
may play an important role in disease evolution, either by (not reducing) solar exposure or as a 
surrogate for generally poor occupational conditions. Consistent with this, and line with previous cross-
harvest studies17 we identified an association between rapid decline and a cane/seed cutting role (a 
job role that has been associated with particularly hot working conditions) in a sensitivity analysis 
examining associations with exposures assessed post-harvest.  
The lack of association of self-reported physical effort the previous week at work, and both work in very 
hot environment and combined dehydration/heat stress symptoms in the last 6 months, with the 
outcome measure both at baseline, and in the sensitivity analysis with exposures assessed at visit 2 
raises further questions. Although self-reported measures of thermal sensation and physical exertion 
have been shown to robustly capture acute physiological heat stress27 our (similar) instruments (and/or 
our combined measure of heat-symptoms) may not be valid in the rural Nicaraguan population or may 
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not reflect time-accumulated heat stress. Alternatively, we may have had inadequate power to detect 
heat stress as a partial contributor to eGFR decline or otherwise it may be that non-heat related 
occupational exposures promote the development of CKDu. Finally the association between self-
reported fever over the previous 6-months at the second study visit and rapid decline trajectory might 
support a proposed infective/inflammatory contributor to MeN28, though this finding was from a 
sensitivity analysis and should be treated with caution. 
In summary, our data do not provide clear evidence for a cause to the disease. Along with occupation 
the importance of non-occupational factors is supported by: (i) the range of jobs undertaken by the 
men experiencing rapid decline, and (ii) the 3.4% of women in our study who also showed a rapid loss 
of eGFR. As others have suggested,2 separate initiating and exacerbating factors should be considered 
as occurs in other forms of CKD. For example, the progression of kidney disease due to known causes 
(e.g. diabetes, glomerulonephritis) can be exacerbated by episodes of volume depletion. Therefore, 
the possibility of an initial (currently unknown) sub-clinical insult, which is then exacerbated by the 
harsh working conditions might explain the increased rates of eGFR loss and excess of advanced 
disease in men. 
Although other studies have identified changes in urinary biomarkers in sugarcane workers over the 
harvest season in Mesoamerica29 none have examined associations with subsequent eGFR loss over 
the medium-term. There were no associations between dipstick proteinuria or ACR, and eGFR 
trajectory group. Although albuminuria is a strong risk factor for renal decline in most populations, this 
is consistent with previous reports from Mesoamerica where patients with established CKDu show only 
low-grade proteinuria.6,24,30 Urinary NGAL levels were substantially raised in those with baseline 
dysfunction but levels in the rapid decline group overlapped with the stable group making this test 
poorly predictive at an individual level. 
Finally, it is worth noting the seasonal variation of eGFR in the population. Other studies (unrelated to 
CKDu) have described similar seasonal differences in renal function31,32 so whether this this variation 
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is in any way related to the factors that cause MeN is unclear but this finding does need to be 
considered when interpreting the change in eGFR reported in cross-harvest studies5,18. Ideally, any 
future longitudinal biomarker study should be of more than one-year duration to ensure that small falls 
in eGFR do not reflect cyclical seasonal changes.   
Our study has several strengths. Overall response rates were high and the eGFR was estimated using 
robust methods. We excluded those with self-report of diabetes and hypertension in an attempt to 
focus our study on eGFR decline due to MeN and the prospective nature of our study enabled us to 
identify those with aggressive disease without necessarily meeting definitions for CKD. Furthermore 
we excluded those with established renal disease (either by self-report from the study as a whole or 
by examining only those with preserved eGFR at baseline for the risk-factor analysis) and hence 
overcome issues associated with reverse causation.  
Our study also has limitations. We did not formally exclude diabetes in our participants. Although often 
undiagnosed,33 the prevalence of diabetes is low in Nicaraguans of this age-group34 and none of those 
in the rapid decline group demonstrated albuminuria (or glycosuria; data not presented) making an 
underlying diabetic lesion highly unlikely. We also relied on self-report to quantify the majority of 
occupational and environmental exposures. Although questionnaire-based assessments are useful 
instruments, none of them have been validated in the Nicaraguan population so some exposures may 
be prone to misclassification. The study took place in a confined geographical area which limits 
generalizability.  Resources restricted our study to a moderate sample size and we had to alter our 
statistical approach. We were nonetheless able to detect a number of strong associations with eGFR 
trajectory but the analytical change did lead to a reduction in power. Therefore we would have expected 
to identify associations with a primary cause of disease that had been reliably captured by 
questionnaire but may have missed weaker associations particularly with contributing exposures. The 
baseline dysfunction group are unrepresentative due to selection criteria (those with established CKD 
were intentionally excluded at recruitment) and possibly survivor bias (due to the small number of 
deaths in this group) and the nature of the study design means the relationship between rapid decline 
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in eGFR and hard outcomes could not be described. However, we hope to perform extended follow-
up to investigate the longer-term outcomes in the cohort. Finally, the CKD-EPI formula has not been 
validated for this population, although as we were interested in within-person change in eGFR this is 
unlikely to be of major importance. 
In conclusion, this is the first community-based cohort study that describes the natural history of eGFR 
in those at risk of MeN. Almost 10% of apparently healthy young men, and 3.4% of young women 
showed a marked decline in kidney function. Additional studies with at least 1-year follow-up are 
needed to understand the causes of this decline, including the risks associated with outdoor 
(agricultural) work. Efforts to identify biomarkers of this early loss of eGFR, rather than established 
disease, are essential to gain a better understanding of aetiology, as well as to identify the population(s) 
that would benefit from interventions. A combined, multidisciplinary approach is called for, in 
partnership with the affected communities and local employers, to address this devastating disease. 
  
15 
 
AUTHOR CONTRIBUTIONS 
BC and NP conceived the project. MG-Q, DN, CW, JG, JLeB, AA, LS NP and BC designed the study. 
MG-Q, AC, DF, JLeB, and BC performed the fieldwork along with the fieldwork team. MG-Q, RS, DN, 
NP and BC analysed and interpreted the data. ES, BG, AO and MH analyzed the biological samples. 
MG-Q, RS, DN, NP and BC drafted the manuscript. All authors read, critically appraised and approved 
the final manuscript. 
ACKNOWLEDGEMENTS AND FINANCIAL DISCLOSURES 
The authors would like to thank the participants, and each of the community leaders for their support 
during the data collections across study visits. We would also like to thank the interview team, drivers, 
phlebotomists, and staff of the Research Centre for Health, Work and Environment, National 
Autonomous University of Nicaragua at Leon, for their assistance during the study.  
The study was supported by a grant from the UK Colt Foundation. In addition, the Dutch National 
Postcode Lottery provided funding to Solidaridad to support a proportion of the fieldwork costs. No 
funding source was involved in any part of the study design, or the decision to submit the manuscript 
for publication.  
Disclosures: none. 
 
 
 
 
  
16 
 
REFERENCES 
1. Ordunez, P., et al. The epidemic of chronic kidney disease in Central America. Lancet Glob 
Health 2, e440-441 (2014). 
2. Wegman, D., et al. Mesoamerican nephropathy: report from the second international research 
workshop on MeN. in SALTRA, Vol. 33 (ed. Central American Institute for Studies on Toxic Substances 
(IRET-UNA) and Program on Work, E.a.H.i.C.A.S.) (SALTRA/IRET-UNA, Heredia, C.R, 2016). 
3. Orantes, C.M., et al. Epidemiology of chronic kidney disease in adults of Salvadoran agricultural 
communities. MEDICC Rev 16, 23-30 (2014). 
4. Ordunez, P., et al. Chronic kidney disease epidemic in Central America: urgent public health 
action is needed amid causal uncertainty. PLoS neglected tropical diseases 8, e3019 (2014). 
5. Peraza, S., et al. Decreased kidney function among agricultural workers in El Salvador. Am J 
Kidney Dis 59, 531-540 (2012). 
6. Torres, C., et al. Decreased kidney function of unknown cause in Nicaragua: a community-
based survey. Am J Kidney Dis 55, 485-496 (2010). 
7. Jayatilake, N., Mendis, S., Maheepala, P., Mehta, F.R. & Team, C.K.N.R.P. Chronic kidney 
disease of uncertain aetiology: prevalence and causative factors in a developing country. BMC Nephrol 
14, 180 (2013). 
8. Ministry of Health Nutrition and Indigenous Medicine - Medical Statistics Unit. Annual health 
bulletin of Sri Lanka 2015., Vol. 2017 (ed. Unit., M.S.) (Ministry of Health, Nutrition and Indigenous 
Medicine, Sri Lanka, 2017). 
9. Wijkstrom, J., et al. Morphological and clinical findings in Sri Lankan patients with chronic 
kidney disease of unknown cause (CKDu): Similarities and differences with Mesoamerican 
Nephropathy. PloS one 13, e0193056 (2018). 
10. Rajapurkar, M.M., et al. What do we know about chronic kidney disease in India: first report of 
the Indian CKD registry. BMC Nephrol 13, 10 (2012). 
11. El Minshawy, O., Ghabrah, T. & El Bassuoni, E. End-stage renal disease in Tabuk Area, Saudi 
Arabia: an epidemiological study. Saudi J Kidney Dis Transpl 25, 192-195 (2014). 
12. Correa-Rotter, R., Wesseling, C. & Johnson, R.J. CKD of unknown origin in Central America: 
the case for a Mesoamerican nephropathy. Am J Kidney Dis 63, 506-520 (2014). 
13. Riefkohl, A., et al. Leptospira seropositivity as a risk factor for Mesoamerican Nephropathy. 
International journal of occupational and environmental health, 1-10 (2017). 
14. Valcke, M., Levasseur, M.E., Soares da Silva, A. & Wesseling, C. Pesticide exposures and 
chronic kidney disease of unknown etiology: an epidemiologic review. Environ Health 16, 49 (2017). 
15. O'Donnell, J.K., et al. Prevalence of and risk factors for chronic kidney disease in rural 
Nicaragua. Nephrol Dial Transplant 26, 2798-2805 (2011). 
16. Wesseling, C., et al. Heat stress, hydration and uric acid: a cross-sectional study in workers of 
three occupations in a hotspot of mesoamerican nephropathy in Nicaragua. BMJ Open 6, 1-12 (2016). 
17. Laws, R.L., et al. Changes in kidney function among Nicaraguan sugarcane workers. 
International journal of occupational and environmental health 21, 241-250 (2015). 
18. Wesseling, C., et al. Kidney function in sugarcane cutters in Nicaragua--A longitudinal study of 
workers at risk of Mesoamerican nephropathy. Environ Res 147, 125-132 (2016). 
17 
 
19. González-Quiroz, M., Caplin, B., Pearce, N. & Nitsch, D. What do epidemiological studies tell 
us about chronic kidney disease of undetermined cause in Meso-America? A systematic review and 
meta-analysis,. Clinical Kidney Journal sfx136(2017). 
20. González-Quiroz, M., et al. Rationale, description and baseline findings of a community-based 
prospective cohort study of kidney function among the young rural population of Northwest Nicaragua. 
BMC Nephrol 18(2017). 
21. Inker, L.A., et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N 
Engl J Med 367, 20-29 (2012). 
22. Boucquemont, J., Heinze, G., Jager, K., Oberbauer, R. & Leffondre, K. Regression methods 
for investigating risk factors of chronic kidney disease outcomes: the state of the art. BMC Nephrol 15, 
45 (2014). 
23. Nylund, K.L., Asparouhov, T. & Muthén, B.O. Deciding on the Number of Classes in Latent 
Class Analysis and Growth Mixture Modeling: A Monte Carlo Simulation Study. Structural Equation 
Modeling: A Multidisciplinary Journal 14, 535-569 (2007). 
24. Wijkstrom, J., et al. Renal Morphology, Clinical Findings, and Progression Rate in 
Mesoamerican Nephropathy. Am J Kidney Dis 69, 626-636 (2017). 
25. Goderis, G., et al. Long-term evolution of renal function in patients with type 2 diabetes mellitus: 
a registry-based retrospective cohort study. BMJ Open 3, e004029 (2013). 
26. Boucquemont, J., et al. Identifying subgroups of renal function trajectories. Nephrol Dial 
Transplant 32, ii185-ii193 (2017). 
27. Chan, A.P. & Yang, Y. Practical on-site measurement of heat strain with the use of a perceptual 
strain index. Int Arch Occup Environ Health 89, 299-306 (2016). 
28. Fischer, R.S.B., et al. Early detection of acute tubulointerstitial nephritis in the genesis of 
Mesoamerican nephropathy. Kidney Int 93, 681-690 (2018). 
29. Laws, R.L., et al. Biomarkers of Kidney Injury Among Nicaraguan Sugarcane Workers. Am J 
Kidney Dis 67, 209-217 (2016). 
30. Gracia-Trabanino, R., Dominguez, J., Jansa, J.M. & Oliver, A. [Proteinuria and chronic renal 
failure in the coast of El Salvador: detection with low cost methods and associated factors]. Nefrologia 
25, 31-38 (2005). 
31. Masugata, H., et al. Seasonal variation in estimated glomerular filtration rate based on serum 
creatinine levels in hypertensive patients. Tohoku J Exp Med 224, 137-142 (2011). 
32. Ranucci, M., Castelvecchio, S., La Rovere, M.T., Surgical & Clinical Outcome Research, G. 
Renal function changes and seasonal temperature in patients undergoing cardiac surgery. Chronobiol 
Int 31, 175-181 (2014). 
33. Barcelo, A., et al. Prevalence of diabetes and intermediate hyperglycemia among adults from 
the first multinational study of noncommunicable diseases in six Central American countries: the 
Central America Diabetes Initiative (CAMDI). Diabetes Care 35, 738-740 (2012). 
34. Iniciativa Centroamericana de Diabetes (CAMDI). Encuesta de Diabetes, Hipertensión y 
Factores de Riesgo de Enfermedades Crónicas.  (2009). 
  
18 
 
Table 1. Selected demographic, lifestyle and occupational characteristics of the study cohort  
Characteristic 
Overall 
(n=350) 
Males  
(n=263) 
Females  
(n=87) 
Personal and Lifestyle Factors 
Age in years; mean (SD) 23.9 (3.7) 23.7 (3.8) 24.2 (3.6) 
Educational level; n (%)    
 Illiteracy 18 (5.1) 18 (6.8) 0 (0) 
 Primary school 176 (50.3) 133 (50.6) 43 (49.4) 
 Secondary school 138 (39.5) 100 (38.0) 38 (43.7) 
 Higher education 18 (5.1) 12 (4.6) 6 (6.9) 
Body mass index; median (IQR) 22.7 (21.0–25.0) 22.4 (20.8–24.1) 24.5 (21.9–30.0) 
Systolic blood pressure mmHg; median (IQR) 117 (109 – 124) 119 (111 – 125) 109 (103 – 119) 
Diastolic blood pressure mmHg; median (IQR) 68 (63 – 73) 68 (63 - 74) 68 (63 – 72) 
Household income in Córdobas/month; median 
(IQR) 
6000 (4000–9200) 6000 (4000–10000) 5120 (3380–8144) 
Family history of CKD; n (%)    
 Yes 165 (47.1) 126 (47.9) 39 (44.8) 
 No 185 (52.9) 137 (52.1) 48 (55.2) 
Annual alcohol consumption   
in grams; median (IQR) 
0·0 (0–849) 82.9 (0–1350) 0.0 (0–0) 
Smoking pack-year; median (IQR) 0·0 (0–0) 0·0 (0–1) 0.0 (0–0) 
NSAID use ever; n (%)    
 Never 58 (16·6) 49 (18·6) 9 (10·3) 
 Occasionally 251 (71·7) 185 (70·3) 66 (75·9) 
 Regularly 31 (8·9) 23 (8·8) 8 (9·2) 
 Daily 10 (2·8) 6 (2·3) 4 (4·6) 
Water sources; n (%)    
 Piped wáter 186 (53.1) 139 (52.9) 47 (54.0) 
 Dug well 126 (36.0) 98 (37.2) 28 (32.2) 
 Drilled well 38 (10.9) 26 (9.9) 12 (13.8) 
Water Hardness; n (%)    
 Soft 0 (0·0) 0 (0·0) 0 (0·0) 
 Moderately hard 97 (27·7) 67 (25·4) 30 (34·5) 
 Hard 160 (45·7) 123 (46·8) 37 (42·5) 
 Very hard 93 (26·6) 73 (27·8) 20 (23·0) 
Total liquid in last 24hrs; median (IQR) 5.0 (3.7–6.3) 5.6 (4.2–6.7) 3.6 (2.5–4.5) 
Occupational Factors 
Current occupation; n (%)    
 Sugarcane 55 (15.7) 45 (17.1) 10 (11.5) 
 Banana work   14 (4.0) 13 (4.9) 1 (1.1) 
 Other agricultural work 115 (32.9) 109 (41.5) 6 (6.9) 
 Commerce 14 (4.0) 5 (1.9) 9 (10.3) 
 Construction 10 (2.9) 10 (3.8) 0 (0) 
 Fishing 7 (2.0) 7 (2.7) 0 (0) 
 Homeworker 54 (15.4) 0 (0) 54 (62.1) 
 Student 6 (1.7) 4 (1.5) 2 (2.3) 
 Unemployed 51 (14.6) 49 (18.6) 2 (2.3) 
 Other occupations* 24 (6.8) 21 (8.0) 3 (3.5) 
Main sugarcane role (if ever worked in 
sugarcane); n (%) 
   
 Cane cutter 81 (23.2) 81 (30.8) 0 (0) 
 Seed cutter 56 (16.3) 56 (21.3) 0 (0) 
 Seeder 67 (19.2) 47 (17.9) 21 (24.1) 
 Cane cleaner 26 (7.4) 17 (6.5) 9 (10.4) 
 Pesticide applicator 4 (1.1) 4 (1.5) 0 (0) 
 Cane irrigator 8 (2.3) 8 (3.0) 0 (0) 
 Driver 4 (1.1) 4 (1.5) 0 (0) 
 Never worked in sugarcane 103(29.4) 46 (17.5) 57 (65.5) 
Current or previous banana work; n (%)    
 Yes 56 (16.0) 47 (17.9) 9 (10.3) 
 No 294 (84.0) 216 (82.1) 78 (89.7) 
Years in sugarcane; mean (SD) 2.2 (2.8) 2.8 (2.8) 0.67 (1.7) 
Years in agricultura; mean (SD) 3.6 (4.4) 4.3 (4.5) 1.2 (3.3) 
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Characteristic 
Overall 
(n=350) 
Males  
(n=263) 
Females  
(n=87) 
Work carried out ;† n (%)    
 Indoors 136(38.9) 69 (26.2) 67 (77.0) 
 Outdoors 214 (61.1) 194 (73.8) 20 (23.0) 
Work in a hot environment;†  n (%)    
 Irregularly 137 (39.2) 92 (35.0) 45 (51.7) 
 Regularly 74 (21.1) 57 (21.7) 17 (19.5) 
 Frequently  139 (39.7) 114 (43.3) 25 (28.8) 
 Always 0 (0) 0 (0) 0 (0) 
Shade availability;† n (%)    
 Yes 254 (72.6) 190 (72.2) 64 (73.6) 
 No 96 (27.4) 73 (27.8) 23 (26.4) 
Duration of breaks  in mins;†  
median (IQR) 
20 (10-30) 15.0 (10 - 30) 30.0 (20- 60) 
Physical effort at work;‡ n (%)    
 Did not work 15 (4.3) 14 (5.3) 1 (1.2) 
 Slight  142 (40.6) 100 (38.0) 42 (48.3) 
 Moderate 155 (44.2) 119 (45.3) 36 (41.4) 
 Hard 38 (10.9) 30 (11.4) 8 (9.2) 
Glyphosate use;†,§  n (%)    
 Yes  77 (22.0) 77 (29.3) 0 (0)  
 No 273 (78.0) 186 (70.7) 87 (100.0) 
Paraquat use;†,§ n (%)    
   Yes  44 (12.6) 44 (16.7) 0 (0)  
   No 306 (87.4) 219 (83.3) 87 (100.0) 
Cypermethrin use;†,§  n (%)    
 Yes  75 (21.4) 73 (27.7) 2 (2.3)  
 No 275 (78.6) 190 (72.2) 85 (97.7) 
Methomyl use;†,§  n (%)    
 Yes  12 (3.4) 12 (4.6) 0 (0)  
 No 338 (96.6) 251 (94.4) 87 (100.0) 
Clinical history/symptoms 
Heat/dehydration symptoms;† n (%)    
 Yes 240 (68·6) 175 (66·5) 65 (74·7)  
 No 110 (31·4) 88 (33·5) 22 (25·3) 
UTI in the previous year; n (%)    
 Yes 91 (26.0) 56 (21.3) 35 (40.2) 
 No 259 (74.0) 207 (78.7) 52 (59.8) 
Weight loss;† n (%)    
 Yes 63 (18.0) 55 (20.9) 8 (9.2) 
 No 287 (82.0) 208 (79.1) 79 (90.8) 
Dysuria†    
 Yes 94 (26.9) 72 (27.4) 22 (25.3) 
 No 256 (73.1) 191 (72.6) 65 (74.7) 
Fever†    
 Yes 36 (10.3) 32 (12.2) 4 (4.6) 
 No 314 (89.7) 231 (87.8) 83 (95.4) 
Study Visits and Outcome 
Initial serum creatinine, mg/dl; median (IQR) 0.81 (0.70–0.90) 0.84 (0.77–0.94) 0.63 (0.57–0.68) 
Final serum creatinine, mg/dl; median (IQR) 0.81 (0.70–0.90) 0.91 (0.80–1.03) 0.64 (0.57–0.72) 
Initial cystatin C, mg/L; median (IQR) 0.82 (0.74–0.92) 0.85 (0.77–0.95) 0.72 (0.67–0.80) 
Final cystatin C, mg/L; median (IQR) 0.84 (0.76–0.94) 0.88 (0.80–1.01) 0.72 (0.67–0.80) 
Initial eGFR, mL/min/1.73m2; median (IQR) 118.3 (106.6 – 125.4) 116.2 (102.4 – 124.6) 122.0 (116.3 – 127.2) 
Final eGFR, mL/min/1.73m2; median (IQR) 113.1 (99.4 – 122.3) 110.4 (92.5 – 120.1) 120.2 (110.6 – 126.6) 
Abbreviations: CKD: Chronic Kidney Disease; NSAID: Non-steroidal anti-inflammatory drug; eGFR: estimated glomerular filtration rate using 
CKD EPI equation based on creatinine and cystatin c; UTI: diagnosed with a urinary tract infection typically without microbiological or dipstick 
confirmation. *Other occupations include: teacher, painter, shoemaker, security, manufacturing operator and barber; †over the last 6-months; 
‡over the last week; §Data collected at second visit; Questionnaire data prior to recoding are presented in Appendix Table 1.  
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Table 2. Age and education level adjusted associations of rapid decline in kidney function by 
baseline exposure in male study participants*  
Characteristic 
Preserved and stable 
eGFR 
 
Rapid decline in eGFR 
Reference  OR 95% CI 
Alcohol consumption      
 Any 1.00  1.69 0.70 to 4.10 
 None 1.00  Reference Reference 
NSAID use      
 Daily/regularly 1.00  1.28 0.34 to 4.74 
 Never/occasionally 1.00  Reference Reference 
Water sources      
 Piped water 1.00  0.79 0.34 to 1.81 
 Dug well/drilled well 1.00  Reference Reference 
Water hardness      
 Softly/moderately hard 1.00  1.21 0.47 to 3.11 
 Hard/very hard 1.00  Reference Reference 
Total liquid in last 24hrs      
 >5.0 litres/day 1.00  1.01 0.43 to 2.38 
 ≤ 5.0 litres/day 1.00  Reference Reference 
Current occupation      
 Sugarcane 1.00  1.51 0.31 to 7.29 
 Agricultural work 1.00  3.57 1.14 to 11.13 
 Other occupations/EIP 1.00  Reference Reference 
Main sugarcane role (if ever 
worked in sugarcane) 
    
 Cane/seed cutter 1.00  2.15 0.57 to 8.06 
 Seeder 1.00  1.82 0.40 to 8.20 
 Other cane jobs 1.00  0.94 0.14 to 6.08 
 Never worked in sugarcane 1.00  Reference Reference 
Current or historical banana work     
 Yes 1.00  1.77 0.60 to 5.18 
 No 1.00  Reference Reference 
Years in sugarcane  1.00  1.02 0.87 to 1.19 
Years in agriculture  1.00  0.99 0.89 to 1.09 
Work carried out†     
 Outdoors 1.00  10.35 1.35 to 79.24 
 Indoors 1.00  Reference Reference 
Work in a hot environment†     
 Regular/frequently 1.00  0.46 0.20 to 1.06 
 Irregularly 1.00  Reference Reference 
Shade availability†     
 No 1.00  3.74 1.59 to 8.76 
 Yes or inside 1.00  Reference Reference 
Duration of breaks†     
 ≤ 10 minutes 1.00  1.86 0.80 to 4.33 
 >10 minutes 1.00  Reference Reference 
Physical effort at work‡     
 Moderate/hard 1.00  1.40 0.59 to 3.32 
 None/slight  1.00  Reference Reference 
Agrochemicals†,§     
 Yes 1.00  1.70 0.72 to 4.03 
 No  1.00  Reference Reference 
Heat/dehydration symptoms†      
 Yes 1.00  1.40 0.55 to 3.55 
 No 1.00  Reference Reference 
Dysuria†     
 Yes 1.00  1.18 0.48 to 2.89 
 No 1.00  Reference Reference 
Fever†     
 Yes 1.00  2.41 0.80 to 7.27 
 No 1.00  Reference Reference 
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Abbreviations: OR: odds ratio; NSAID: Non-steroidal anti-inflammatory drug; UTI: urinary tract infection: EIP: Economically Inactive 
Population. Agricultural work includes all non-sugarcane agricultural work. * Probability weighted according to results of growth mixture 
model; †over the last 6-months.; ‡over the last week; §Data collected at second visit, includes glyphosate, cypermethrin, paraquat and 
methomyl 
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Table 3: Description of urinary findings at baseline by assigned eGFR trajectory groups in males  
Urine findings Overall 
(n=263) 
Preserved and 
stable eGFR 
 (n=213) 
Rapid decline in 
eGFR  
(n=25) 
Baseline 
dysfunction  
 (n=25) 
Urinary specific gravity (n, %)     
≤ 1020 256 (97.3) 207 (97.2) 24 (96.0) 25 (100.0) 
>1020 7 (2.7) 6 (2.8) 1 (4.0) 0 (0) 
Protein (n, %)     
Negative 224 (85.2) 181 (85.0) 22 (88.0) 21 (84.0) 
Trace 25 (9.5) 19 (8.9) 2 (8.0) 4 (16.0) 
Positive 14 (5.3) 13 (6.1) 1 (4.0) 0 (0) 
ACR (n, %)     
≥ 30 mg/g 15 (5.7) 11 (5.2) 0 (0) 4 (16.0) 
< 30 mg/g 248 (94.3) 201 (94.8) 25 (100.0) 21 (84.0) 
Participants assigned to the group with the highest probability in growth mixture model. Abbreviations: ACR: 
Albumin creatinine ratio. P=NS by Fishers exact test for differences by group.  
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Table 4: Description of urinary findings at baseline by assigned eGFR trajectory groups in females.  
Urine findings Overall 
(n=87) 
Preserved and 
stable eGFR 
 (n=84) 
Rapid decline in 
eGFR  
(n=3) 
Urinary specific gravity (n, %)    
≤ 1020 81 (93.1) 79 (94.1) 2 (66.7) 
>1020 6 (6.9) 5 (5.9) 1 (33.3) 
Protein (n, %)    
Negative 70 (80.5) 68 (81.0) 2 (66.7) 
Trace 13 (14.9) 12 (14.3) 1 (33.3)) 
Positive 4 (4.6) 4 (4.7) 0 (0) 
ACR (n, %)    
≥ 30 mg/g 9 (10.3) 9 (10.7) 0 (0) 
< 30 mg/g 78 (89.7) 75 (89.3) 3 (100.0) 
Participants assigned to the group with the highest probability in growth mixture model. Abbreviations: ACR: 
Albumin creatinine ratio. Given the small number in some cells no statistical tests were performed.  
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FIGURE LEGENDS 
Figure 1: Study outline. Location of the nine study communities in Nicaragua (A). Cartoon showing 
study timeline along with population, recruitment and follow-up numbers (B). Two participants died 
from end-stage renal disease. 
Figure 2: Box-and whisker plot of eGFR across the study population. Median eGFR was lower 
post-harvest than pre-harvest. The dashed line represents the median eGFR in the population at 
baseline.  
Figure 3: eGFR in the assigned kidney trajectory groups over the 2-year follow-up period. Three 
subgroups were identified in the 263 males (A) and two in 87 females (B). Each blue line represents 
the individual eGFR of a single participant. Each participant was allocated to the group of highest 
probability derived from the growth mixture model. Coefficients for the three male groups: preserved 
and stable eGFR (n=213; intercept [mean eGFR at baseline], 113.3  mL/min/1.73m2, 95% CI, 111.3 to 
115.3; slope [mean eGFR decline over time]  -0.6 mL/min/1.73m2/year, 95% CI, 0.0 to -0.9); rapid 
decline in eGFR (n=25; intercept, 109.5 mL/min/1.73m2, 95% CI, 99.1 to 119.9; slope, -18.2 
mL/min/1.73m2/year, 95% CI, -13.5 to -22.9; and baseline dysfunction (n=25; intercept 55.6 
mL/min/1.73m2, 95% CI, 48.5 to 62.7; slope, -3.8 mL/min/1.73m2/year, 95% CI, -0.7 to -6.9 . 
Coefficients for the two female groups: preserved and stable eGFR (n=84; intercept, 120.5 
mL/min/1.73m2, 95% CI, 118.1 to 122.9; slope, -0.6 mL/min/1.73m2/year, 95% CI, 0.2 to -1.4) but we 
also identified a small number with rapid decline in kidney function (n=3; intercept, 127.5 
mL/min/1.73m2, 95% CI, 119.3 to 135.7; slope, -14.6 mL/min/1.73m2/year, 95% CI,-7.5 to -21.7). 
Figure 4: Box-and-whisker plot of urinary NGAL/creatinine concentrations by assigned eGFR 
trajectory group among male study participants. Lines: median; Boxes: interquartile range; 
Whiskers: 1.5x interquartile range; Dots: outlying values. Stable group, n=55; Rapid decline group, 
n=25; Baseline dysfunction, n=24. *P=0.031; ****P= <0.001 using ANOVA followed by Dunnett’s 
multiple comparisons test (using stable and preserved eGFR group as reference). 
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1. Supplementary Methods 
Communities and population: The study was conducted in 9 rural communities in Leon and 
Chinandega regions of Northwest Nicaragua. Most of these communities had not previously 
taken part in CKD research but one had taken part in previous studies. Following engagement 
activities the study team enumerated the de jure  population aged 18-30 of each village by 
visiting dwellings and liaison with families and community leaders.  Comparison with current 
local government data suggests the sampling frame n=520 represented 10-15% of the total 
population (including children) of the area. Internal and external migration means that numbers 
of adults in this age range are relatively underrepresented in these rural communities.  
 
Questionnaire data, clinical measures and water samples: We collected exposure 
variables using a questionnaire, the details of which are available elsewhere.1 In addition, at 
the second visit, we also asked participants to report any use of glyphosate, paraquat, 
methomyl, and cypermethrin with assistance from a visual catalogue.  
Questionnaire data were collected at baseline and each study visit on:  
A. Demographics: age, education, household income per month, water sources, and social 
security status. 
B. Occupational history: current occupation, history of sugarcane work ever, predominant 
sugarcane job if ever worked in sugarcane, current and historical banana work, previous job 
duration, and number of sugarcane harvests or pre-harvests worked.  
C. Current occupational exposures: daily work hours, duration of breaks, location of work, 
experience of a hot working environment, availability of shade during work breaks, physical 
effort last week at work, weight loss at work. 
D. Lifestyle factors: grams of alcohol consumption over the last year, smoking pack-years, 
liquid (water and soft drinks) intake in last 24-hours, and use of nephrotoxic medications at 
any time.  
E. Self-reported symptoms in the last 6-months, separated into: (i) heat-related/dehydration 
symptoms: headache, tachycardia, muscle cramps in the arms, or legs, fever, nausea, 
difficulty breathing, muscle weakness, dizziness, vomiting, fainting, dysuria, dry mouth, very 
dark urine, very little urine, extremely tired and confusion);2-4 (ii) self-reported weight loss (iii) 
self-reported diagnoses of urinary tract infection in the previous year. Original symptom 
questionnaire responses for the whole population are summarised in Supplementary Table 1. 
 
Height, weight and blood pressure were measured using standard procedures and calibrated 
devices.  
 
Water was collected from participants' primary water source at baseline and second visit only. 
Water was collected and stored in polypropylene containers at 4°C. Water hardness was 
calculated from the sum of calcium and magnesium cations (as calcium carbonate, in mg/L), 
measured using inductively coupled plasma mass-spectrometry at Imperial College London. 
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Urine and serum markers: All biosamples were stored at 4°C on collection, frozen at the end 
of the study day (-20°C, for up to 2 weeks), and then stored at -80°C following transfer to the 
UK. Dipstick (Siemens multistix, SG10) analysis was performed on previously frozen urine 
samples to assess protein, and specific gravity semi-quantitatively. Albumin was quantified 
using a colorimetric method with bromocresol green Albumin Assay Kit (Sigma-Aldrich, 
MAK124). Baseline urine samples from men, previously frozen, and stored at -80°C for 2.5 
years were analysed for Neutrophil Gelatinase-Associated Lipocalin (NGAL): fifty-five 
randomly selected from the stable kidney function group and all of those in the rapid decliners 
in kidney and established renal dysfunction at baseline status groups. NGAL was measured 
using enzyme-linked immunoassay (ELH-Lipocalin2, RayBiotech) according to 
manufacturer’s instructions. Albumin and NGAL were expressed as the ration to urinary 
creatinine measured using the Jaffe method (Sigma-Aldrich C4255). 
 
Serum creatinine (sCr) and cystatin C (sCys) were both measured in a single batch analysis 
of all 1581 stored study samples at Nuffield Department of Population Health Wolfson 
Laboratories from the Clinical Trials Services Unit (CTSU), Oxford University, using quality 
control referenced to isotope dilution mass spectrometry traceable international standards. 
sCr was quantified using a Beckman AU680 Chemistry Analyser (Jaffe compensated method) 
and sCys was measured using Siemens BN ProSpec (nephelometry). Mean expanded 
uncertainty values: 3% at both 2.2mg/dL and 4.7mg/dL for sCr; 8% at 0.7mg/L and 6% at 
2.1mg/L for sCys. The CKD EPI formula for serum creatinine - cystatin C was then used to 
estimate GFR.  
 
Exposure variables: The original frequencies of self-reported symptoms (prior to recoding) 
are presented in Supplementary Table 1. Prior to association analyses income was recoded 
using the World Bank definition of poverty of an income of US $1.90/day and educational level 
as illiteracy or attendance at primary-level education versus attendance at secondary- or 
higher-level education. Current occupation was grouped into sugarcane work, other 
agricultural work, and other occupations/economically inactive population; predominant sugar 
cane role was categorised (by potential heat exposure) as (cane/seed) cutters, seeders or 
other roles; work breaks as <10 minutes or >10 minutes; self-reported occupational 
agrochemical exposure as use of any of glyphosate, paraquat, cypermethrin, or methomyl; 
and, the degree of physical effort in last week at work as none or slight versus moderate or 
hard. Lifestyle risk factors included daily alcohol consumption averaged over the last year was 
defined as none (0 grams for both sexes) versus any (1-60 grams for males and 1-40 grams 
for females), and current smoking status classified as never smokers (0 pack-years) versus 
light smokers (1-20 pack-years). Non-steroidal anti-inflammatory drugs use was recoded as 
daily or regularly versus occasionally or never. Self-reported diagnosis of urinary tract infection 
was also recorded. Self-reported symptoms were categorized as positive for any one heat-
related/dehydration symptom, alongside fever, dysuria and self-reported weight loss. 
 
Three variables related to fluid consumption were analysed: water sources (piped water, water 
from a dug well/drilled well) and total liquid intake in last 24 hours (≤5 liters/day, and >5 
liters/day). Water hardness was grouped based as soft/moderately hard (0-120 mg/L), and 
hard/very hard (≥121 mg/L).  
 
Additional statistical methods 
Continuous variables were summarized by means and standard deviations or medians and 
interquartile range, and categorical variables by frequency/percentages. For the further 
analyses, non-normally distributed continuous variables were categorised, and ordinal 
variables were recoded to avoid small cell numbers (see Supplementary Table 1). 
  
We found a multi-level linear model had poor fit with non-normally distributed residuals as 
eGFR trajectories clustered in sub-populations and differently between men and women. 
Therefore we used a growth mixture modeling (GMM) approach. We identified three 
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subpopulations of eGFR trajectory in men and two in women, primarily by using the Bayesian 
Information Criterion as suggested in this setting.5 Adjustment for season of follow-up visit did 
not substantially affect the estimation of eGFR trajectories so was not included in the model. 
 
Associations between individual exposure variables and outcome were examined using 
probability-weighted multinomial logistic regression. Individuals’ probabilities of each kidney 
function status were obtained from the GMM. These models were adjusted for age and 
educational level as these variables might confound the association between casual factors 
of interest and outcome. 95% confidence intervals of odds ratios that did not include unity 
were accepted as significant. As these association models consisted of exploratory analyses 
no formal adjustments for multiple testing were performed.  
 
The original study sample of 350 was calculated to achieve 90% power to detect associations 
with acceleration in eGFR decline of 5.0 mL/min/1.73m2/year in a linear model to which at 
least 20% of the population were exposed, at alpha 0.01. Given the change in analysis 
strategy we performed a post-hoc power calculation. Using a chi-squared test to detect 
differences in kidney function status (e.g. stable versus rapid decline) associated with an 
exposure (to which half the population are exposed) there would be over 80% power to detect 
an odds ratio of 3.8 or greater. With a non-exposed prevalence of 4.5% this reflects a similar 
power to detect an exposure that multiplies the risk by 3.3. This estimate is likely to be 
conservative as the analysis was based on a probability-weighted kidney function status, an 
outcome that is likely to be a more precise measure of disease spectrum than an absolute 
categorical grouping. 
 
The coefficients for exposures from the poorly fitting multi-level model, with eGFR measures 
clustered within participants including random intercept and slope, are included as 
Supplementary Table 7 (for information). 
 
Analyses were performed using Stata v14 (Stata Corp.), Prism v7 (Graphpad Software) and 
Mplus (Muthén & Muthén). 
 
 
2. Ethics approval and consent to participate  
All participants signed a written informed consent to participate in the follow-up study, in 
accordance to the Declaration of Helsinki. The study was approved by the bioethical review 
board at the Medical Faculty of UNAN-León (Ref: FWA00004523/IRB00003342), and the 
research ethics committee of the London School of Hygiene and Tropical Medicine (Ref: 
8643/14363) in 2014. 
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4. Supplementary Tables  
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Supplementary Table 1. Symptoms reported over the last 6 months reported at baseline 
Symptom  Overall (%) 
(n=350) 
Males  
(n=263) 
Females  
(n=87) 
Heat-related/dehydration symptoms    
Headache (n, %)    
Yes 139 (39.7) 103 (39.2) 36 (41.4)  
No 211 (60.3) 160 (60.8) 51 (58.6) 
Tachycardia (n, %)    
Yes 40 (11.4) 27 (10.3) 13 (14.9)  
No 310 (88.6) 236 (89.7) 74 (85.61) 
Muscle cramps in the arms or legs (n, %)    
Yes 42 (12.0) 32 (12.2) 10 (11.5)  
No 308 (88.0) 231 (87.8) 77 (88.5) 
Muscle weakness (n, %)    
Yes 6 (1.7) 2 (0.8) 4 (4.6)  
No 344 (98.3) 261 (99.2) 83 (95.4) 
Fever (n, %)    
Yes 36 (10.3) 32 (12.2) 4 (4.6)  
No 314 (89.7) 231 (87.8) 83 (95.4) 
Nausea (n, %)    
Yes 25 (7.1) 22 (8.4) 3 (3.5)  
No 325 (92.9) 241 (91.6) 84 (96.5) 
Difficulty breathing (n, %)    
Yes 16 (4.6) 11 (4.2) 5 (5.8)  
No 334 (95.4) 252 (95.8) 82 (94.2) 
Dizziness (n, %)    
Yes 26 (7.4) 15 (5.7) 11 (12.6)  
No 324 (92.6) 248 (94.3) 76 (87.4) 
Vomiting (n, %)    
Yes 8 (2.3) 8 (3.0) 0 (0)  
No 342 (97.7) 255 (97.0) 87 (100.0) 
Fainting (n, %)    
Yes 7 (2.0) 5 (1.9) 2 (2.3)  
No 343 (98.0) 258 (98.1) 85 (97.7) 
Dysuria (n, %)    
Yes 94 (26.9) 72 (27.4) 22 (25.3)  
No 256 (73.1) 191 (72.6) 65 (74.7) 
Dry mouth (n, %)    
Yes 75 (21.4) 56 (21.3) 19 (21.8)  
No 275 (78.6) 207 (78.7) 68 (78.2) 
Very dark urine (n, %)    
Yes 21 (6.0) 12 (4.6) 9 (10.3)  
No 329 (94.0) 251 (95.4) 78 (89.7) 
Very little urine (n, %)    
Yes 30 (8.6) 16 (6.1) 14 (16.1)  
No 320 (91.4) 247 (93.9) 73 (83.9) 
Extremely tired (n, %)    
Yes 29 (8.3) 19 (7.2) 10 (11.5)  
No 321 (91.7) 244 (92.8) 77 (88.5) 
Confusion (n, %)    
Yes 12 (3.4) 8 (3.0) 4 (4.6)  
No 338 (96.6) 255 (97.0) 83 (95.4) 
.  
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Supplementary Table 2. Baseline demographic, lifestyle characteristics of male study participants, stratified by assigned 
eGFR trajectory group* (n=263) 
Characteristic 
Preserved and stable 
kidney function  
 (n=213) 
Rapid decline in 
eGFR 
(n=25) 
Dysfunction at baseline 
 (n=25) 
Age, years; mean (SD) 23.6 (3.8) 23.3 (3.6) 25.4 (2.9) 
Educational level; n (%)    
 Illiteracy/primary  121 (56.8) 14 (56.0) 16 (64.0) 
 Secondary/higher  92 (43.2) 11 (44.0) 9 (36.0) 
Body mass index; n, (%)    
 Normal 176 (82.6) 18 (72.0) 21 (84.0) 
 Overweight/Obese 37 (17.4) 7 (28.0) 4 (16.0) 
Systolic blood pressure mmHg; median (IQR) 118 (110 – 124) 120 (113 – 127) 126 (119 – 129) 
Diastolic blood pressure mmHg; median (IQR) 69 (63 – 73) 70 (66 – 76) 74 (68 – 78) 
Income; n (%)    
 Poor 108 (50.7) 16 (64.0) 14 (56.0) 
 Not por 105 (49.3) 9 (36.0) 11 (44.0) 
Family history of CKD; n (%)    
 Yes 103 (48.4) 11 (44.0) 12 (48.0) 
 No 110 (51.6) 14 (56.0) 13 (52.0) 
Alcohol consumption; n (%)    
 Any  112 (52.6) 16 (64.0) 13 (52.0) 
 None 101 (47.4) 9 (36.0) 12 (48.0) 
Smoking history; n (%)    
 Light smokers 81 (38.0) 10 (40.0) 12 (48.0) 
 Never smokers 132 (62.0) 15 (60.0) 13 (52.0) 
NSAID use; n (%)    
 Daily-regularly 21 (9.9) 3 (12.0) 5 (20.0) 
 Never-occasionally 192 (90.1) 22 (88.0) 20 (80.0) 
Water sources;  n (%)    
 Piped wáter 115 (54.0) 12 (48.0) 12 (48.0) 
 Dug well/drilled well 98 (46.0) 13 (52.0) 13 (52.0) 
Water hardness; n (%)    
 Soft/moderately hard 51 (23.9) 7 (28.0) 9 (36.0) 
 Hard/very hard 162 (76.1) 18 (72.0) 16 (65.0) 
Total liquid in last 24hrs; n (%)    
 ≤ 5.0 litres  86 (40.4) 10 (40.0) 9 (36.0) 
 >5.0 litres 127 (59.6) 15 (60.0) 16 (64.0) 
Current occupation; n (%)    
 Sugarcane 38 (17.8) 3 (12.0) 4 (16.0) 
 Agricultural work 98 (46.0) 18 (72.0) 15 (60.0) 
 Other occupations/EIP 77 (36.2) 4 (16.0) 6 (24.0) 
Main sugarcane role (if ever worked in 
sugarcane) (%) 
   
 Cane/seed cutter 103 (48.4) 15 (60.0) 19 (76.0) 
 Seeder 39 (18.3) 5 (20.0) 3 (12.0) 
 Other cane Jobs 30 (14.1) 2 (8.0) 1 (4.0) 
 Never worked in sugarcane 41 (19.3) 3 (12.0) 2 (8.0) 
Current or historical banana work; n (%)    
 Yes 27 (12.9) 5 (20.0) 15 (60.0) 
 No 186 (87.3) 20 (80.0) 10 (40.0) 
Years in sugarcane; mean (SD) 2.7±2.9 2.7±2.7 3.6±2.8 
Years in agriculture; mean (SD) 4.3±4.5 4.0±3.9 5.4±4.5 
Work carried out;† n (%)    
 Indoors 62 (29.1) 1 (4.0) 6 (24.0) 
 Outdoors 151 (70.9) 24 (96.0) 19 (76.0) 
Work in a hot environment;† n (%)    
 Irregularly 71 (33.3) 13 (52.0) 8 (32.0) 
 Regular/frequently 142 (66.7) 12 (48.0) 17 (68.0) 
Shade availability;† n (%)    
 Yes or inside 159 (74.7) 11 (44.0) 20 (80.0) 
 No 54 (25.3) 14 (56.0) 5 (20.0) 
Duration of breaks;† n (%)    
 ≤ 10 minutes 63 (29.6) 11 (44.0) 12 (48.0) 
 >10 minutes 150 (70.4) 14 (56.0) 13 (52.0) 
Physical effort at work;‡ n (%)    
 None/slight  94 (44.1) 9 (36.0) 11 (44.0) 
 Moderate/hard 119 (55.9) 16 (64.0) 14 (56.0) 
Agrochemicals;†, § n (%)    
 Yes 109 (51.2) 16 (64.0)  10 (40.0) 
 No  104 (48.8) 9 (36.0) 15 (60.0) 
Heat/dehydration symptoms;† n (%)    
 Yes 139 (65.3) 18 (72.0)  18 (72.0) 
 No 74 (34.7) 7 (28.0) 7 (28.0) 
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Characteristic 
Preserved and stable 
kidney function  
 (n=213) 
Rapid decline in 
eGFR 
(n=25) 
Dysfunction at baseline 
 (n=25) 
UTI diagnosis in the previous year; n (%)    
 Yes 42 (19.7) 5 (20.0) 9 (36.0) 
 No 171 (80.3) 20 (80.0) 16 (64.0) 
Weight loss;† n (%)    
 Yes 42 (19.7) 7 (28.0) 6 (24.0) 
 No 171 (80.3 18 (72.0) 19 (76.0) 
Dysuria †    
 Yes 61 (28.6) 8 (32.0) 3 (12.0) 
 No 152 (71.4) 17 (68.0) 22 (88.0) 
Fever†    
 Yes 21 (9.9) 5 (20.0) 6 (24.0) 
 No 192 (90.1) 20 (80.0) 19 (76.0) 
Baseline eGFR, mL/min/1.73m2; median (IQR) 117.9 (107.6 - 125.4) 116.5 (102.6 - 123.8) 55.5 (49.4 - 67.5) 
Second eGFR, mL/min/1.73m2; median (IQR) 114.7 (104.5 - 122.3) 101.4 (91.2 - 108.9) 51.6 (44.6 - 64.6) 
Third eGFR, mL/min/1.73m2; median (IQR) 115.3 (104.0 - 123.1) 103.0 (85.7 - 108.9) 55.0 (43.9 - 65.7) 
Fourth eGFR, mL/min/1.73m2; median (IQR) 113.4 (105.5 - 121.6) 74.3 (62.7 - 84.3) 48.5 (39.0 - 56.8) 
Final eGFR, mL/min/1.73m2; median (IQR) 113.7 (103.8 - 121.9) 77.1 (66.6 - 84.3) 53.2 (45.0 – 59.7) 
Abbreviations: CKD: Chronic Kidney Disease; NSAID: Non-steroidal anti-inflammatory drug; eGFR: estimated 
glomerular filtration rate using CKD EPI equation based on creatinine and cystatin c; UTI: urinary tract infection. EIP; 
Economically Inactive Population. Agricultural work includes all non-sugarcane agricultural work. *Participants 
assigned to the group with the highest probability in growth mixture model. †over the last 6-months; ‡over the last 
week; §Data collected at second visit. Includes glyphosate, cypermethrin, paraquat and methomyl 
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Supplementary Table 3.  Baseline demographic, lifestyle characteristics of female study participants, stratified by 
assigned eGFR trajectory group* (n=87) 
Characteristic Preserved and stable eGFR  (n=84) 
Rapid decline in eGFR 
(n=3) 
Age, years; mean (SD) 24.3 ± 3.6 21.7 ± 3.0 
Educational level; n (%)   
 Illiteracy/primary  41 (48.8) 2 (66.7) 
 Secondary/higher  43 (51.2) 1 (33.3) 
Body mass index; n, (%)   
 Normal 46 (54.8) 1 (33.3) 
 Overweight/Obese 38 (45.2) 2 (66.7) 
Systolic blood pressure mmHg; median (IQR) 109 (102 – 117) 125 (103 – 133) 
Diastolic blood pressure mmHg; median (IQR) 67 (63 – 72) 74 (67 – 75) 
Income; n (%)   
 Poor 50 (59.5) 1 (33.3) 
 Not por 34 (40.5) 2 (66.7) 
Family history of CKD; n (%)   
 Yes 37 (44.1) 2 (66.7) 
 No 47 (55.9) 1 (33.3)  
Alcohol consumption; n (%)   
 Any  7 (8.3) 1 (33.3) 
 None 77 (91.7) 2 (66.7) 
Smoking history; n (%)   
 Light smokers 1 (1.2) 0 (0) 
 Never smokers 83 (98.8) 3 (100.0) 
NSAID use; n (%)   
 Daily-regularly 11 (13.1) 1 (33.3) 
 Never-occasionally 73 (86.9) 2 (66.7) 
Water sources;  n (%)   
 Piped wáter 45 (53.6) 2 (66.7) 
 Dug well/drilled well 39 (46.4) 1 (33.3) 
Water hardness; n (%)   
 Soft/moderately hard 28 (33.3) 2 (66.7) 
 Hard/very hard 56 (66.7) 1 (33.3) 
Total liquid in last 24hrs; n (%)   
 ≤ 5.0 litres  70 (83.3) 3 (100.0) 
 >5.0 litres 14 (16.7) 0 (0) 
Current occupation; n (%)   
 Sugarcane 10 (11.9) 0 (0) 
 Agricultural work 6 (7.1) 1 (33.3) 
 Other occupations/EIP 68 (81.0) 2 (66.7) 
Main sugarcane role (if ever worked in sugarcane); n  (%)   
 Cane/seed cutter 0 (0) 0 (0) 
 Seeder 21 (25.0) 0 (0) 
 Other cane Jobs 9 (10.7) 0 (0) 
 None  54 (64.3) 3 (100.0) 
Current or historical banana work; n (%)   
 Yes 9 (10.7) 0 (0) 
 No 75 (89.3) 3 (100.0) 
Years in sugarcane; mean (SD) 0.6±1.7 0±0 
Years in agriculture; mean (SD) 1.2±3.4 0.3±0.5 
Work carried out;† n (%)   
 Indoors 65 (77.4) 2 (66.7) 
 Outdoors 19 (22.6) 1 (33.3) 
Work in a hot environment;† n (%)   
 Irregularly 43 (51.2) 2 (66.7) 
 Regular/frequently 41 (48.8) 1 (33.3) 
Shade availability;† n (%)   
 Yes or inside 62 (73.8) 2 (66.7) 
 No 22 (26.2) 1 (33.3) 
Duration of breaks;† n (%)   
 ≤ 10 minutes 14 (16.7) 1 (33.3) 
 >10 minutes 70 (83.3) 2 (66.7) 
Physical effort at work;‡ n (%)   
 None/slight  42 (50.0) 1 (33.3) 
 Moderate/hard 42 (50.0) 2 (66.7) 
Agrochemicals;†, § n (%)   
 Yes 12 (14.3) 0 (0) 
 No  72 (85.7) 3 (100.0) 
Heat/dehydration symptoms;† n (%)   
 Yes 63 (75.0) 2 (66.7) 
 No 21 (25.5) 1 (33.3) 
UTI diagnosis in the previous year; n (%)   
 Yes 34 (40.5) 1 (33.3) 
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Characteristic Preserved and stable eGFR  (n=84) 
Rapid decline in eGFR 
(n=3) 
 No 50 (59.5) 2 (66.7) 
Weight loss;† n (%)   
 Yes 8 (9.5) 0 (0) 
 No 76 (90.5) 3 (100.0) 
Dysuria †   
 Yes 21 (25.0) 1 (33.3) 
 No 63 (75.0) 2 (66.7) 
Fever†   
 Yes 4 (4.8) 0 (0) 
 No 80 (95.2) 3 (100.0) 
Baseline eGFR, mL/min/1.73m2; median (IQR) 121.8 (115.8 – 127.1) 136.3 (123.3 – 136.4) 
Second eGFR, mL/min/1.73m2; median (IQR) 118.9 (109.1 – 128.2) 107.5 (91.5 – 136.7) 
Third eGFR, mL/min/1.73m2; median (IQR) 119.5 (113.0 – 126.6) 102.3 (93.1 – 108.2) 
Fourth eGFR, mL/min/1.73m2; median (IQR) 119.4 (112.7 – 124.9) 99.9 (95.9 – 108.0) 
Final eGFR, mL/min/1.73m2; median (IQR) 121.4 (112.1 – 126.6) 102.2 (102.0 – 103.1) 
Abbreviations: CKD: Chronic Kidney Disease; NSAID: Non-steroidal anti-inflammatory drug; eGFR: estimated 
glomerular filtration rate using CKD EPI equation based on creatinine and cystatin c; UTI: urinary tract infection. EIP; 
Economically Inactive Population. Agricultural work includes all non-sugarcane agricultural work. *Participants 
assigned to the group with the highest probability in growth mixture model. †over the last 6-months; ‡over the last 
week; §Data collected at second visit. Includes glyphosate, cypermethrin, paraquat and methomyl 
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Supplementary Table 4. Occupational characteristics, heat symptoms and liquid intake at visit 2 for males recruited at 
the first study visit only, stratified by assigned eGFR trajectory group* (n=213) 
Characteristic 
Preserved 
and stable 
eGFR  
(n=176) 
Rapid decline 
in eGFR  
(n=18) 
Dysfunction at 
baseline 
(n=19) 
Total liquid in last 24hrs; n (%)    
 ≤ 5.0 litres 18 (10.2) 2 (11.1) 2 (10.5) 
 >5.0 litres 158 (89.8) 16 (88.9) 17 (89.5) 
Current occupation; n (%)    
Sugarcane 89 (50.6) 10 (55.6) 5 (26.3) 
Agricultural work 54 (30.7) 4 (22.2) 11 (57.9) 
Other occupations/EIP 33 (18.7) 4 (22.2) 3 (15.8) 
Predominant sugarcane role;† n (%)    
Cane/seed cutter 32 (18.1) 9 (50.0) 4 (21.1) 
Seeder 33 (18.8) 4 (22.2) 0 (0) 
Other cane jobs 39 (22.2) 0 (0) 4 (21.1) 
Not worked in sugarcane  72 (40.9) 5 (27.8) 11 (57.9) 
Months in sugarcane;† mean (SD) 2.9±2.7 4.2±2.5 1.2±2.2 
Months in agriculture;† mean (SD) 1.6±2.3 0.4±1.4 3.0±2.5 
Work carried out;† n (%)    
Indoors 39 (22.2) 3 (16.7) 5 (26.3) 
Outdoors 137 (77.8) 15 (83.3) 14 (73.7) 
Work in a hot environment;† n (%)    
Irregularly 36 (20.5) 4 (22.2) 7 (36.8) 
Regular/frequently 140 (79.5) 14 (77.8) 12 (63.2) 
Shade availability;† n (%)    
Yes or inside 161 (91.5) 17 (94.4) 18 (94.7) 
No 15 (8.5) 1 (5.6) 1 (5.3) 
Duration of breaks;† n (%)    
≤ 10 minutes 69 (39.2) 8 (44.4) 7 (36.8) 
>10 minutes 107 (60.8) 10 (55.6) 12 (63.2) 
Physical effort at work;‡ n (%)    
Slight  60 (34.1) 5 (27.8) 4 (21.1) 
Moderate/hard 116 (65.9) 13 (72.2) 15 (78.9) 
Weight loss at work;† n (%)    
Yes 41 (23.3) 3 (16.7) 2 (10.5) 
No 135 (76.7) 15 (83.3) 17 (89.5) 
Heat/dehydration symptoms;† n (%)    
Yes 127 (72.2) 12 (66.7) 14 (73.7) 
No 49 (27.8) 6 (33.3) 5 (26.3) 
Dysuria †    
 Yes 58 (32.9) 3 (16.7) 3 (15.8) 
 No 118 (67.1) 15 (83.3) 16 (84.2) 
Fever†    
 Yes 36 (20.4) 10 (55.6) 7 (36.8) 
 No 140 (79.6) 8 (44.4) 12 (63.2) 
Abbreviations: EIP; Economically Inactive Population. Agricultural work includes all non-sugarcane agricultural work. 
. *Participants assigned to the group with the highest probability in growth mixture model. †Over the last 6-months; 
‡over the last week;  
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 Supplementary Table 5. Age and education level adjusted associations* of rapid decline trajectory with 
exposures at visit 2 among in male study participants (n= 213) 
 
 
Abbreviations: OR: odds ratio; Agricultural work includes all non-sugarcane agricultural work. EIP: Economically Inactive 
Population. *Probability weighted according to results of growth mixture model; †over the last 6-months.; ‡over the last week;  
Characteristic 
Preserved and stable eGFR 
(n=176)  Rapid decline in eGFR (n=18) 
Reference   OR 95% CI 
Alcohol consumption      
 Any 1.00  1.04 0.38 to 2.78 
 None 1.00  Reference Reference 
Total liquid in last 24hrs      
 ≤ 5.0 litres 1.00  1.08 0.22 to 5.16 
 >5.0 litres 1.00  Reference Reference 
Current occupation     
 Sugarcane 1.00  0.84 0.24 to 2.96 
 Agricultural work 1.00  0.59 0.13 to 2.59 
 Other occupations/EIP 1.00  Reference Reference 
Main sugarcane role†      
 Cane/seed cutter 1.00  3.84 1.17 to 12.58 
 Seeder 1.00  1.59 0.38 to 6.52 
 Other cane Jobs 1.00  -- -- 
 Not worked in sugarcane 1.00  Reference Reference 
Months in sugarcane†  1.00  1.20 0.98 to 1.46 
Months in agriculture†  1.00  0.71 0.49 to 1.02 
Work carried outa     
 Outdoors 1.00  1.25 0.33 to 4.65 
 Indoors 1.00  Reference Reference 
Work in a hot environment†     
 Regular/frequently 1.00  0.81 0.24 to 2.70 
 Irregularly 1.00  Reference Reference 
Shade availability†      
 No 1.00  0.58 0.07 to 4.75 
 Yes or inside 1.00  Reference Reference 
Duration of breaks†     
 ≤ 10 minutes 1.00  1.27 0.47 to 3.42 
 >10 minutes 1.00  Reference Reference 
Physical effort at work‡      
 Moderate/hard 1.00  1.27 0.43 to 3.77 
 Slight  1.00  Reference Reference 
Heat/dehydration symptoms†      
 Yes 1.00  0.81 0.28 to 2.29 
 No 1.00  Reference Reference 
Dysuria †     
 Yes 1.00  0.42 0.11 to 1.52 
 No 1.00  Reference Reference 
Fever†     
 Yes 1.00  5.77 2.03 to 16.33 
 No 1.00  Reference Reference 
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Supplementary Table 6. Age and education level adjusted associations* of baseline kidney dysfunction with 
baseline exposures in male study participants  
 
Characteristic 
Preserved and stable 
eGFR 
 Baseline dysfunction 
Reference  OR 95% CI 
Alcohol consumption      
 Any 1.00  0.85 0.36 to 1.99 
 None 1.00  Reference Reference 
NSAID use      
 Daily/regularly 1.00  2.00 0.65 to 6.10 
 Never/occasionally 1.00  Reference Reference 
Water sources      
 Piped water 1.00  0.74 0.32 to 1.74 
 Dug well/drilled well 1.00  Reference Reference 
Water hardness      
 Softly/moderately hard 1.00  2.13 0.86 to 5.29 
 Hard/very hard 1.00  Reference Reference 
Total liquid in last 24hrs      
 >5.0 litres/day 1.00  1.18 0.49 to 2.83 
 ≤ 5.0 litres/day 1.00  Reference Reference 
Current occupation      
 Sugarcane 1.00  1.82 0.46 to 7.20 
 Agricultural work 1.00  2.26 0.81 to 6.32 
 Other occupations/EIP 1.00  Reference  Reference 
Main sugarcane role (if ever worked in 
sugarcane)     
 Cane/seed cutter 1.00  3.16 0.69 to 14.47 
 Seeder 1.00  1.36 0.21 to 8.79 
 Other cane jobs 1.00  0.59 0.05 to 7.01 
 Never worked in sugarcane 1.00  Reference Reference 
Current or historical banana work     
 Yes 1.00  9.40 3.79 to 23.30 
 No 1.00  Reference Reference 
Years in sugarcane  1.00  1.03 0.90 to 1.18 
Years in agriculture  1.00  1.02 0.93 to 1.11 
Work carried out†     
 Outdoors 1.00  1.39 0.51 to 3.78 
 Indoors 1.00  Reference Reference 
Work in a hot environment†     
 Regular/frequently 1.00  1.03 0.42 to 2.55 
 Irregularly 1.00  Reference Reference 
Shade availability†     
 No 1.00  0.79 0.27 to 2.23 
 Yes or inside 1.00  Reference Reference 
Duration of breaks†     
 ≤ 10 minutes 1.00  2.36 1.01 to 5.55 
 >10 minutes 1.00  Reference Reference 
Physical effort at work‡     
 Moderate/hard 1.00  1.00 0.43 to 2.33 
 None/slight  1.00  Reference Reference 
Agrochemicals†,§     
 Yes 1.00  0.61 0.26 to 1.45 
 No  1.00  Reference Reference 
Heat/dehydration symptoms†      
 Yes 1.00  1.22 0.47 to 3.12 
 No 1.00  Reference Reference 
Dysuria†     
 Yes 1.00  0.33 0.09 to 1.17 
 No 1.00  Reference Reference 
Fever†     
 Yes 1.00  2.58 0.88 to 7.54 
 No 1.00  Reference Reference 
Abbreviations: OR: odds ratio; NSAID: Non-steroidal anti-inflammatory drug; UTI: urinary tract infection: EIP: Economically Inactive 
Population. Agricultural work includes all non-sugarcane agricultural work. *Probability weighted according to results of growth 
mixture model; †over the last 6-months.; ‡over the last week; §Data collected at second visit, includes glyphosate, cypermethrin, 
paraquat and methomyl 
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Supplementary Table 7. Age and education level adjusted multilevel analysis of association of baseline 
exposures with eGFR change over follow-up in the male population*   
Characteristic n 
Difference in rate of change 
in eGFRScr-Scys 
(mL/min/1·73m2/year) 
95% confidence interval 
Alcohol consumption     
 Any 141 -0.19 -2·14 to 1·75 
 None 122 Reference [-1·99] Reference  
NSAID use     
 Daily/regularly 29 -1.04 -4·13 to 2·04 
 Never/occasionally 234 Reference [-1·96] Reference  
Water sources     
 Piped water 139 -0.71 -2·65 to 1·23 
 Dug well/drilled well 124 Reference [-1·69] Reference  
Water hardness     
 Softly/moderately hard 67 -0.37 -2·58 to 1·82 
 Hard/very hard 196 Reference [-1·95] Reference  
Total liquid in last 24hrs     
 >5.0 litres/day 85 -0.33 -2·42 to 1·74 
 ≤ 5.0 litres/day 178 Reference [-1·97] Reference  
Current occupation     
 Sugarcane 45 -0.28 -3·23 to 2·67 
 Agricultural work 131 -2.51 -4·65 to -0·37 
 Other occupations/EIP 87 Reference [-0·67] Reference  
Main sugarcane role (if ever worked in 
sugarcane)    
 Cane/seed cutter 137 -0.25 -2·92 to 2·41 
 Seeder 47 -1.18 -4·44 to 2·07 
 Other cane jobs 33 0.04 -3·51 to 3·59 
 Never worked in sugaracane 46 Reference [-1·81] Reference  
Current or historical banana work    
 Yes 47 0.90 -1·57 to 3·39 
 No 216 Reference [-2·46] Reference  
Years in sugarcane  -- -1.10 -2.03 to -0.17 
Years in agriculture  -- 0.11 -0.47 to 0.69 
Work carried out†    
 Outdoors 194 -3.08 -5·23 to -0·92 
 Indoors 69 Reference [0·19] Reference  
Work in a hot environment†    
 Regular/frequently 171 1.17 -0·84 to 3·18 
 Irregularly 92 Reference [-2·82] Reference  
Shade availability†    
 No 73 -3.70 -5·79 to -1·61 
 Yes or inside 190 Reference [-1·01] Reference  
Duration of breaks†    
 ≤ 10 minutes 86 -2.16 -4·22 to -0·09 
 >10 minutes 177 Reference [-1·37] Reference  
Physical effort at work‡    
 Moderate/hard 149 -1.31 -3·25 to 0·62 
 None/slight  114 Reference [-1·35] Reference  
Agrochemicals†,§    
 Yes 135 -1.26 -3·20 to 0·67 
 No  128 Reference [-1·45] Reference  
Heat/dehydration symptoms†     
 Yes 175 -0.69 -2·75 to 1·35 
 No 88 Reference [-1·62] Reference  
Dysuria †    
 Yes 72 -0.26 -2·45 to 1·92 
 No 191 Reference [-1·99] Reference  
Fever†    
 Yes 32 -1.74 -4·71 to 1·22 
 No 231 Reference [-1·89] Reference  
Abbreviations: NSAID: Non-steroidal anti-inflammatory drug; UTI: urinary tract infection: EIP: Economically Inactive Population. Agricultural work 
includes all non-sugarcane agricultural work. *Coefficients estimated from the eGFR*time interaction. Model demonstrates poor fit and provided for 
information only. †over the last 6-months.; ‡over the last week; §Data collected at second visit, includes glyphosate, cypermethrin, paraquat and 
methomyl 
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Supplementary Figures 
 
Supplementary Figure 1: Distribution of eGFR trajectories in the study population. eGFR decline 
calcuated by ordinary least squares. The sub-group of those with rapid eGFR decline can be seen as a 
small but distinct group of values centring at -20mL/min/1.7m2/year.  
 
 
Supplementary Figure 2: Serum creatinine levels in the different eGFR trajectory groups over time 
in (A) men and (B) women.  
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Supplementary Figure 1  
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Supplementary Figure 2.  
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